![](https://investorshub.advfn.com/uicon/68757.png?cb=1512550973)
Friday, February 22, 2019 2:01:34 PM
On February 22, 2019, the Board of Directors of Heyu Biological Technology Corporation (the “Company”) decided that the Company would focus on the production and sale in China of medical equipment designed to fight cancer. The Company is cooperating with a research team led by Professor Yu Xu, a researcher in the treatment of cancer, to produce and sell their Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, which is a new product based on submillimeter wave theory of therapy. The Company is finalizing the design of this new product and is in the process of seeking government approval for its production and sale in China.
Forward-Looking Statements
This Current Report on Form 8-K includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “project,” “anticipate,” “expect,” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM